Thioredoxin system modulation by plant and fungal secondary metabolites

Current Medicinal Chemistry

Volumn 17, Issue 5, 2010, Pages 479-494

  Dal Piaz, F ^a   Braca, A ^b   Belisario, M A ^a   De Tommasi, N ^a  

^a UNIVERSITY OF SALERNO   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Fungal secondary metabolites; Plant secondary metabolites; Thioredoxin systems

Indexed keywords

1 METHYLPROPYL 2 IMIDAZOLYL DISULFIDE; 13 HYDROXY 15 OXO ZOAPATLIN; ANTHRACYCLINE; CATECHIN; CHALCONE; CURCUMIN; DAUNORUBICIN; FORSKOLIN; HELENALIN; JUGLONE; LUTEOLIN; MK 3018; MYRICETIN; PALMARUMYCIN; PELARGONIDIN; PLEUROTIN; POLYPHENOL DERIVATIVE; PROTEIN INHIBITOR; PX 12; PX 916; QUERCETIN; QUINONE DERIVATIVE; RESVERATROL; RIBONUCLEOTIDE REDUCTASE; SCUTELLARIN; TAXIFOLIN; TEPRENONE; TERPENE; TERPENOID DERIVATIVE; THIOREDOXIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; CARCINOGENESIS; CELL DEATH; CELL GROWTH; CELL SURVIVAL; CLINICAL TRIAL; DRUG STRUCTURE; HUMAN; IC 50; NONHUMAN; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CURCUMIN; ENZYME INHIBITORS; FLAVONOIDS; FUNGI; PHENOLS; PLANTS; THIOREDOXIN-DISULFIDE REDUCTASE; THIOREDOXINS;

EID: 77950663504     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986710790226165     Document Type: Review

References (106)

1. Holmgren, A. Thioredoxin. Annu. Rev. Biochem., 1985, 54, 237-271.
2. Arner, E.S.; Holmgren, A. Physiologic function of thioredoxin and thioredoxin reductase. Eur. J. Biochem., 2000, 267, 6102-6109.
3. Holmgren, A. Thioredoxin and glutaredoxin systems. J. Biol. Chem., 1989, 264, 13963-13966.
4. Powis, J.; Kirkpatrick, D.L. Thioredoxin signalling as a target for cancer therapy. Curr. Opin. Pharmacol., 2007, 7, 392-397. (Pubitemid 47289261)
5. Hirota, K.; Matsui, M.; Iwata, S.; Nishiyama, A.; Mori, K.; Yodoi, J. AP-1 transcriptional activity is regulated by a direct association between thioredoxin and Ref-1. Proc. Natl. Acad. Sci. USA, 1997, 94, 3633-3638. (Pubitemid 27180424)
6. Makino, J.; Yoshikawa, N.; Okamoto, K.; Hirota, K.; Yodoi, J.; Makino, I; Tanaka, H. Direct association with thioredoxin allows redox regulation of glucocorticoid receptor function. J. Biol. Chem., 1999, 274, 3182-3188. (Pubitemid 29075407)
7. Tamura, T.; Stadtman, T.C. A new selenoprotein from human lung and adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc. Natl. Acad. Sci. USA, 1996, 93, 1006-1011.
8. Zong, L.; Holmgren, A. Essential role of selenium in the catalytic activity of mammalian thioredoxin reductase revealed by characterization of recombinant enzyme with selenocisteine mutations. J. Biol. Chem., 2000, 275, 18121-18128. (Pubitemid 30414762)
9. Mustacich, D.; Powis, G. Thioredoxin reductase. Biochem. J., 2000, 346, 1-8.
10. Nordberg, J.; Arner, E.S.J. Reactive oxygen species, antioxidant, and the mammalian thioredoxin system. Free Radical Bio. Med., 2001, 31, 1287-1312.
11. Arner, E.S.J.; Holmgren, A. The thioredoxin system in cancer. Semin. Cancer Biol., 2006, 16, 420-426.
12. Lincoln, D.T.; Eli Emadi, E.M.; Tonissen, K.F.; Clarke, F.M. The thioredoxin-thioredoxin reductase system: over-expression in human cancer. Anticancer Res., 2003, 23, 2425-2434.
13. Kim, S.J.; Miyoshi, Y.; Taguchi, T.; Tamaki, Y.; Nakamura, H.;Yodoi, J.; Kato, K.; Noguchi, S. High thioredoxin expression is associated with resistance to docetaxel in primary breast cancer. Clin. Cancer Res., 2005, 11, 8425-8430.
14. Baker, A.F.; Dragovich, T.; Tate, W.R.; Ramanathan, R.K.; Roe, D.; Hsu, C.H.; Kirkpatrick, D.L.; Powis, G. The antitumor thioredoxin-1 inhibitor PX-12 (1-methylpropyl 2-imidazolyl disulfide) decreases thioredoxin-1 and VEGF levels in cancer patient plasma. J. Lab. Clin. Med., 2006, 147, 83-90. (Pubitemid 43189000)
15. Butler, M.S. The role of natural product chemistry in drug discovery. J. Nat. Prod., 2004, 67, 2141-2153. (Pubitemid 40092578)
16. Ammon, H.P.; Wahl, M.A. Pharmacology of Curcuma longa. Planta Med., 1991, 57, 1-7.
17. Maheswari, R.K.; Singh, A.K.; Gadippati, J.; Srimal, R.C. Multiple biological activities of curcumin: a short review. Life Sci., 2006, 78, 2081-2087.
18. Choudhuri, T.; Pal, S.; Das, T.; Sa, G. Curcumin selectively induces apoptosis in deregulated cyclin D1-expressed cells at G2 phase of cell cycle in a p53-dependent manner. J. Biol. Chem., 2005, 280, 20059-20068. (Pubitemid 41379535)
19. Fang, J.; Lu, J.; Holmgren, A. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity. J. Biol. Chem., 2005, 280, 25284-25290. (Pubitemid 40934623)
20. Nordberg, J.; Zong, L.; Olmgren, A.; Arner, E.S. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighbouring cysteine residue. J. Biol. Chem., 1998, 273, 10835-10842.
21. Uddin, S.; Khan, A.S.; Al-Kuraya, K.S. Developing curcumin into a viable therapeutic for lymphoma. Expert Opin. Investig. Drugs, 2009,18, 57-67.
22. Liu, Z.; Du, Z-Y.; Huang, Z-S.; Lee, K-S.; Gu, L-Q. Inhibition of thioredoxin reductase by curcumin analogs. Biosci. Biotechnol. Biochem., 2008, 72, 2214-2218.
23. Qiu, X.; Liu, Z.; Shao, W-Y.; Liu, X.; Jing, D-P.; Yu, Y-J.; An, LK.; Huang, S-L.; Bu, X-Z.; Huang, Z-S.; Gu, L-Q. Synthesis and evaluation of curcumin analogues as potential thioredoxin reductase inhibitors. Bioorg. Med Chem., 2008, 16, 8035-8041.
24. Dorai, T.; Aggarwal, B.B. Role of chemopreventive agents in cancer therapy. Cancer Lett., 2004, 215, 129-140. (Pubitemid 39370030)
25. Lu, J.; Papp, L.V.; Fang, J.; Rodriguez-Nieto, S.; Zhivotovsky, B.; Holmgren, A. Inhibition of mammalian thioredoxin reductase by some flavonoids: implications for myricetin and quercetin anticancer activity. Cancer Res., 2006, 66, 4410-4418.
26. Wardman, P. Electron transfer and oxidative stress as key factors in the design of drugs selectively active in hypoxia. Curr. Med. Chem., 2001, 8, 739-761. (Pubitemid 32427904)
27. Kunkel, M.W.; Kirkpatrick, D.L.; Johnson, J.I.; Powis, J. Cell linedirected screening assay for inhibitors of thioredoxin reductase signalling as potential anticancer drugs. Anti-Cancer Drug Des., 1997, 12, 659-670.
28. Wipf, P.; Hopkins, T.D.; Jung, J-K.; Rodriguez, S.; Birmingham, A.; Southwick, E.C.; Lazo, J.S.; Powis, G. New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphtoquinones spiroketal natural product lead. Bioorg. Med. Lett., 2001, 11, 2637-2641. (Pubitemid 32823373)
29. Krohn, K.; Beckman, K.; Florke, U.; Aust, H.J.; Draiger, S.; Shulz, B.; Busemann, S.; Bringmann, G. Biologically active metabolites from fungi, 9. New palmarumycins CP4a and CP5 from Coniothyrium palmarum: structure elucidation, crystal structure analysis and determination of the absolute configuration by CD calculations. Tetrahedron, 1997, 53, 3101-3110. (Pubitemid 27087454)
30. Wipf, P.; Lynch, S.M.; Birmingham, A.; Tamayo, G.; Jimenez, A.; Campos, N.; Powis, G. Natural product based inhibitors of the thioredoxin-thioredoxin reductase system. Org. Biomol. Chem., 2004, 2, 1651-1658.
31. Powis, G.; Wipf, P.; Lynch S.M.; Birmingham A.; Kirkpatrick, D.L. Molecular pharmacology and antitumor activity of palmarumycin-based inhibitors of thioredoxin reductase. Mol. Cancer Ther., 2006, 5, 630-636.
32. Cenas, N.; Nivinskas, H.; Anusevicius, Z.; Sarlauskas, J.; Lederer, F.; Arner, E.S.J. Interactions of quinones with thioredoxin reductase a challenge to the antioxidant role of the mammalian selenoprotein. J. Biol. Chem., 2004, 279, 2583-2592.
33. Lee, I.S.; Shamon, L.A.; Chai, H.B.; Chagwedera, T.E.; Besterman, J.M.; Farnsworth, N.R.; Cordell, G.A.; Pezzuto, J.M.; Kinghorn, A.D. Cell-cycle specific cytotoxicity mediated by rearranged entkaurene diterpenoids isolated from Parinari curatellifolia. Chem-Biol. Interact., 1996, 99, 193-204.
34. Garo, E.; Maillard, M.; Hostettmann, K.; Stoeckli-Evans, H.; Mavi, S. Absolute configuration of a diterpene from Parinari capensis. Helv. Chim. Acta, 1997, 80, 538-544. (Pubitemid 27181798)
35. Braca, A.; Armenise, A.; Morelli, I.; Mendez, J.; Mi, Q.; Chai, H.; Swanson, S. M.; Kinghorn A. D.; De Tommasi, N. Structure of kaurane-type diterpenes from Parinari sprucei and their potential anticancer activity. Planta Med., 2004, 70, 540-550. (Pubitemid 38887912)
36. Rundle, N. T.; Xu, L., Andersen, R. J.; Roberge, M. G2 DNA damage checkpoint inhibition and antimitotic activity of 13-hydroxy-15-oxozoapatlin. J. Biol. Chem., 2001, 276, 48231-48236. (Pubitemid 37370727)
37. Dal Piaz, F.; Nigro, P.; Braca, A.; De Tommasi, N.; Belisario, M.A. 13-hydroxy-15-oxo-zoapatlin, an ent-kaurane diterpene, induces apoptosis in human leukemia cells, affecting thiol-mediated redox regulation. Free Radical Bio. Med., 2007, 43, 1409-1422.
38. Nigro, P.; Dal Piaz, F.; Gallotta, D.; De Tommasi N.; Belisario, M.A. Inhibition of the thioredoxin system is a basis for the antileukemic potential of 13-hydroxy-15-oxo-zoapatlin. Free Radical Bio. Med., 2008, 45, 875-884.
39. Watson, W.H.; Pohl, J.; Montfort, W.R.; Stuchlik, O.; Reed, M.S.; Powis, G.; Jones, D.P. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J. Biol. Chem., 2003, 278, 33408-33415.
40. Trotter, E.W.; Grant, C.M. Non-reciprocal regulation of the redox state of the glutathione-glutaredoxin and thioredoxin systems. EMBO Rep., 2003, 4, 184-188.
41. Casagrande, S.; Bonetto, V.; Fratelli, M.; Gianazza, E.; Eberini, I.; Massignan, T.; Salmona, M.; Chang, G.; Holmgren, A.; Ghezzi, P. Glutathionylation of human thioredoxin: a possible crosstalk between the glutathione and thioredoxin systems. Proc. Natl. Acad. Sci. USA, 2002, 9, 9745-9749. (Pubitemid 34831118)
42. Herout, V.; Romanuk, M.; Sorm, F. Terpenes. LXXI. Helenalin -a further lactone of the guaianolide group. Chemicke Listy pro Vedu a Prumysl, 1956, 50, 985-987.
43. Buchi, G.; Rosenthal, D. Terpenes. VI. The structures of helenalin and isohelenalin. J. Am. Chem. Soc., 1956, 78, 3860-3861.
44. Schmidt, T.J. Toxic activities of sesquiterpene lactones-structural and biochemical aspects. Curr. Org. Chem., 1999, 3, 577-605.
45. Hall, I.H.; Williams, W.L.Jr.; Grippo, A.A.; Lee, K-H.; Holbrook, D.J.; Chaney, S.G. Inhibition of nucleic acid synthesis in P-388 lymphocytic leukaemia cells in culture by sesquiterpene lactones. Anticancer Res., 1988, 8, 33-42.
46. 3 up-regulated protein 1, are differentially regulated by PPARα in human macrophages. J. Mol. Biol., 2008, 384, 564-576.
47. Djavaheri-Mergny, M.; Javelaud, D.; Wietzerbin, J.; Besançon, F. NF-kappaB activation prevents apoptotic oxidative stress via an increase of both thioredoxin and MnSOD levels in TNFalpha-treated Ewing sarcoma cells. FEBS Lett., 2004, 578, 111-115. (Pubitemid 39576110)
48. Haendeler, J.; Popp, R.; Goy, C.; Tischler, V.; Zeiher, A.M.; Dimmeler S. Cathepsin D and H2O2 stimulate degradation of Thioredoxin- 1: implication for endothelial cell apoptosis. J Biol. Chem., 2005, 280, 42945-42951.
49. Jang, Y.C.; Van Remme, H. The mitochondrial theory of aging: insight from transgenic and knockout mouse models. Exp. Gerontol., 2009, 44, 256-260.
50. Pérez, V.I.; Lew, C.M.; Cortez, L.A., Webb, C.R.; Rodriguez, M.; Liu, Y.; Qi, W.; Li, Y.; Chaudhuri, A.; Van Remmen, H.; Richardson, A.; Ikeno, Y. Thioredoxin 2 haploin sufficiency in mice results in impaired mitochondrial function and increased oxidative stress. Free Radical Bio. Med., 2008, 44, 882-892.
51. Hui, K.M.; Wang, X.H.; Xue, H. Interaction of flavones from the roots of Scutellaria baicalensis with the benzodiazepine site. Planta Med., 2000, 66, 91-93. (Pubitemid 30097295)
52. Luo, P.; Zhang, Z.; Yi, T.; Zhang, H.; Liu, X.; Mo, Z. Antiinflammatory activity of the extracts and fractions from Erigeron multiradiatus through bioassay-guided procedures. J. Ethnopharmacol., 2008, 119, 232-237.
53. Gao, R.; Zhu, B.H.; Tang, S.B.; Wang, J.F.; Ren, J. Scutellarein inhibits hypoxia- and moderately-high glucose-induced proliferation and VEGF expression in human retinal endothelial cells. Acta Pharmacol. Sin., 2008, 29, 707-712. (Pubitemid 351799471)
54. Hong, H.; Liu, G.Q. Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci., 2004, 74, 2959-2973. (Pubitemid 38402293)
55. Spedding, G.; Ratty, A.; Middleton, E. Jr. Inhibition of reverse transcriptases by flavonoids. Antiviral. Res., 1989, 12, 99-110.
56. Elatayeb, A.A.; Liu, Q.; Gan, L.; Liu, H.; Xu, H. Antagonistic effect of scutellarin on the toxicity of selenium in rat livers. Biol. Trace Elem. Res., 2004, 98, 253-264. (Pubitemid 38703702)
57. Ross, J.A.; Kasum, C.M. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu. Rev. Nutr., 2002, 22, 19-34.
58. Carlson, R.O.; Aschmies, S.H. Tyrosine kinase activity is essential for interleukin-1 beta-stimulated production of interleukin-6 in U373 human astrocytoma cells. J. Neurochem., 1995, 65, 2491-2499.
59. Gitika, B.; Sai Ram, M.; Sharma, S.K.; Ilavazhagan, G.; Banerjee, P.K. Quercetin protects C6 glial cells from oxidative stress induced by tertiarybutylhydroperoxide. Free Radical Res., 2006, 40, 95-102. (Pubitemid 43023790)
60. Sharma, V.; Mishra, M.; Ghosh, S.; Tewari, R.; Basu, A.; Seth, P.; Sen, E. Modulation of interleukin-1b mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Res. Bull., 2007, 73, 55-63. (Pubitemid 46710246)
61. Gutierrez-Venegas, G.; Kawasaki-Cardenas, P.; Arroyo-Cruz, S.R.; Maldonado-Frias, S. Luteolin inhibits lipopolysaccharide actions on human gingival fibroblasts. Eur. J. Pharmacol., 2006, 541, 95-105. (Pubitemid 44192369)
62. Angeloni, C.; Leoncini, E.; Malaguti, M.; Angelici, S.; Hrelia, P.; Hrelia, S. Role of quercetin in modulating rat cardiomyocyte gene expression profile. Am. J. Physiol. Heart Circ. Physiol., 2008, 294, H1233-43. (Pubitemid 351468719)
63. Akihisa, T.; Tokuda, H.; Ukiya, M.; Iizuka, M.; Schneider, S.; Ogasawara, K.; Mukainaka, T.; Iwatsuki, K.; Suzuki, T.; Nishino, H. Chalcones, coumarins, and flavanones from the exudate of Angelica keiskei and their chemopreventive effects. Cancer Lett., 2003, 201, 133-137.
64. Baba, K.; Taniguchi, M.; Nakata, K. Studies on Angelica keiskei ashitaba. Foods Food Ingredients J. Jpn., 1998, 178, 52-60.
65. Hsieh, H.K.; Lee, T.H.; Wang, J.P.; Wang, J.J.; Lin, C.N. Synthesis and anti-inflammatory effect of chalcones and related compounds. Pharm. Res., 1998, 15, 39-46. (Pubitemid 28080864)
66. Zhu, X.F.; Xie, B.F.; Zhou, J.M.; Fengm G.K.; Liu, Z.C.; Wei, X.Y.; Zhang, F.X.; Liu, M.F., Zeng, Y.X. Blockade of vascular endothelial growth factor receptor signal pathway and antitumor activity of ON-III (2′,4′-dihydroxy-6′-methoxy-3′,5′- dimethylchalcone), a component from Chinese herbal medicine. Mol. Pharmacol., 2005, 67, 1444-1450.
67. Anto, R.J., Sukumaran, K.; Kuttan, G.; Rao, M.N. Subbaraju, V.; Kuttan, R. Anticancer and antioxidant activity of synthetic chalcones and related compounds. Cancer Lett., 1995, 97, 33-37.
68. Shibata, T.; Yamada, T.; Ishii, T.; Kumazawa, S.; Nakamura, H.; Masutani, H.; Yodoi, J.; Uchida, K. Thioredoxin as a molecular target of cyclopentenone prostaglandins. J. Biol. Chem., 2003, 278, 26046-26054. (Pubitemid 36835372)
69. Liu, Y-C.; Hsieh, C.W.; Wu, C-C.; Wung, B-S. Chalcone inhibits the activation of NF-κB and STAT3 in endothelial cells via endogenous electrophile. Life Sci., 2007, 80, 1420-30.
70. Kopp, P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'? Eur. J. Endocrinol., 1998, 138, 619-620.
71. Klinge, C.M.; Blankenship, K.A.; Risinger, K.E.; Bhatnager, S.; Noisin, E.L.; Sumanasekera W.K. Resveratrol and estradiol rapidly activate MAPK signaling through estrogen receptors alpha and beta in endothelial cells. J. Biol. Chem., 2005, 280, 7460-7468.
72. Bertelli, A.A.; Giovannini, L.; Bernini, W.; Migliori, M.; Fregoni, M.; Bavaresco, L. Antiplatelet activity of cis-resveratrol. Drugs Exp. Clin. Res., 1996, 22, 61-63.
73. Ferrero, M.E.; Bertelli, A.E.; Fulgenti, A.; Pellegatta, F.; Corsi, M.M.; Bonfrate, M. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. Am. J. Clin. Nutr., 1998, 68, 1208-1214. (Pubitemid 28550950)
74. Cao, Z.; Fang, J.; Xia, C.; Shi, X.; Jiang, B.H. trans-3,4,5'- Trihydroxystilbene inhibits hypoxia-inducible factor 1alpha and vascular endothelial growth factor expression in human ovarian cancer cells. Clin. Cancer Res., 2004, 10, 5253-5263. (Pubitemid 39099800)
75. Kaga, S.; Zhan, L.; Matsumoto, M.; Maulik, N. Resveratrol enhances neovascularization in the infracted rat myocardium through the induction of thioredoxin-1, hemeoxygenase-1, and vascular endothelial growth factor. J. Mol. Cell. Cardiol., 2005, 39, 813-822. (Pubitemid 41464418)
76. Thirunavukkarasu, M.; Penumathsa, S.; Koneru, V.; Bela, S.; Lijun, Z.; Otani, H.; Bagchi, D.; Das, D.K.; Maulik, N. Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: role of nitric oxide, thioredoxin, and heme oxygenase. Free Radical Bio. Med., 2007, 43, 720-729. (Pubitemid 47102122)
77. Yu, G.P.; Hsieh, C.C.; Wang, L.Y.; Yu, S.Z.; Li, X.L.; Jin, T.H. Green-tea consumption and risk of stomach cancer: a populationbased case-control study in Shanghai, China. Cancer Cause Control, 1995, 6, 532-553.
78. Iso, H.; Date, C.; Wakai, K.; Fukui, M.; Tamakoshi, A.; the JACC Study Group. The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults. Ann. Intern. Med., 2006, 144, 554-562.
79. Frei, B.; Higdon, J.V. Antioxidant activity of tea polyphenols in vitro: evidence from animal studies. J. Nutr., 2003, 133, 3275S- 84S.
80. Higdon, J.V.; Frei, B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit. Rev. Food Sci. Nutr., 2003, 43, 89-143. (Pubitemid 38552312)
81. Paquay, J.B.; Haenen, G.R.; Stender, G.; Wiseman, S.A.; Tijburg, L.B.; Bast, A. Protection against nitric oxide toxicity by tea. J. Agric. Food Chem., 2000, 48, 5768-5772.
82. Sarkar, A.; Bhaduri, A. Black tea is a powerful chemopreventor of reactive oxygen and nitrogen species: comparison with its individual catechin constituents and green tea. Biochem. Biophys. Res. Commun., 2001, 284, 173-178. (Pubitemid 32924324)
83. Takatsume, Y.; Maeta, K.; Izawa, S.; Inoue, Y. Enrichment of yeast thioredoxin by green tea extract through activation of yap1 transcription factor in Saccharomyces cerevisiae. J. Agric. Food Chem., 2005, 53, 332-337. (Pubitemid 40129923)
84. Maeta, K.; Nomura, W.; Takatsume, Y.; Izawa, S.; Inoue, Y. Green tea polyphenols function as prooxidants to activate oxidativestress- responsive transcription factors in yeasts. Appl. Environ. Microbiol., 2007, 73, 572-580. (Pubitemid 46147588)
85. Slaga,T.J. Mechanisms of Tumor Promotion, Vols I-IV. CRC Press: Boca Raton, FL. 1984.
86. Brawn, M.K.; Chiou, W.J.; Leach, K.L. Oxidant induced inactivation of protein kinase C in UC11MG cells. Free Radical Res., 1995, 22, 23-37.
87. Monteiro, H.P.; Stern, A. Redox modulation of tyrosine phosphorylation-dependent signal transduction pathways. Free Radical Bio. Med., 1996, 21, 323-333. (Pubitemid 26271722)
88. Flamigni, F.; Marmiroli, S.; Caldarera, C.M.; Guarnieri, C. Involvement of thiol transferase and thioredoxin dependent systems in the protection of essential thiol groups of ornithine decarboxylase. Biochem. J., 1989, 259, 111-115. (Pubitemid 19100503)
89. Kumar, S.; Holmgren, A. Induction of thioredoxin, thioredoxin reductase and glutaredoxin activity in mouse skin by TPA, a calcium ionophore and other tumor promoters. Carcinogenesis, 1999, 20, 1761-1767. (Pubitemid 29410556)
90. Nishizuka,Y. Studies and perspectives of protein kinase C. Science, 1986, 233, 305-312.
91. Bhat, S.V.; Bajwa, B.S.; Dornauer, H.; DeSouza, N.J.; Fehlhaber, H.W. Structures and stereochemistry of new labdane diterpenoids from Coleus forskohlii Briq. Tetrahedron Lett., 1977, 18, 1669-1672.
92. Saleem, A.M.; Dhasan, P.B.; Rafiullah, M.R.M. Simple and rapid method for the isolation of forskolin form Coleus forskohlii by characoal column chromatography. J. Chromatogr. A, 2006, 1101, 313-314.
93. Agarwal, K.C.; Parks, R.E. Jr. Forskolin: a potential antimetastatic agent. Int. J. Cancer, 1983, 32, 801-804.
94. Laurenza, A.; Sutkowski, E.M.; Seamon, K.B. Forskolin: a specific stimulator of adenylyl cyclase or a diterpene with multiple sites of action? Trends Pharmacol. Sci., 1989, 10, 442-447.
95. Yamamoto, M.; Sato, N.; Tajima, H.; Furuke, K.; Ohira, A.; Honda, Y.; Yodoi, J. Induction of human thioredoxin in cultured human retinal pigment epithelial cells through cyclic AMPdependent pathway: involvement in the cytoprotective activity of prostaglandin E1. Exp. Eye Res., 1997, 65, 645-652. (Pubitemid 27489760)
96. Haridas, V.; Higuchi, M.; Jayatilake, G.S.; Bailey, D.; Mujoo, K.; Blake, M.E.; Arntzen, C.J.; Gutterman, J.U. Avicins: triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation. Proc. Natl. Acad. Sci. USA, 2001, 98, 5821-5826. (Pubitemid 32435726)
97. Haridas, V.; Arntzen, C.J.; Gutterman, J.U. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of NF-κB by inhibiting both its nuclear localization and ability to bind DNA. Proc. Natl. Acad. Sci. USA, 2001, 98, 11557-11562.
98. Haridas, V.; Hanausek, M.; Nishimura, G.; Soehnge, H.; Gaikwad, A.; Narog, M.; Spears, E.; Zoltaszek, R.; Walaszek, Z.; Gutterman, J.U. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. J. Clin. Invest., 2004, 113, 65-73.
99. Tyrrell, R.M.; Pidoux, M. Correlation between endogenous glutathione content and sensitivity of cultured human skin cells to radiation at defined wavelengths in the solar ultraviolet range. Photochem. Photobiol., 1988, 47, 405-412.
100. Tsurugi, T. Process for preparing geranylgeranylacetone from geranyllinalool and methyl acetoacetate. (Eisai R & D Management Co., Ltd., Japan). PCT Int. Appl. (2008), p. 13.
101. Murakami, M.; Muto, Y.; Moriwaki, H.; Ohgo, T. Effect of acyclic polyisoprenoids on the biosynthesis of mannose-labeled glycolipids in rat liver microsomes. Biochem. Biophys. Res. Commun., 1981, 103, 706-712.
102. Terano, A.; Shiga, J.; Hiraishi, H.; Ota, S.; Sugimoto, T. Protective action of tetraprenylacetone against ethanol-induced damage in rat gastric mucosa. Digestion, 1986, 35, 182-188.
103. Hirota, K.; Nakamura, H.; Arai, T.; Ishii, H.; Bai, J,; Itoh, T.; Fukuda, K.; Yodoi, J. Geranylgeranylacetone enhances expression of thioredoxin and suppresses ethanol-induced cytotoxicity in cultured hepatocytes. Biochem. Biophys. Res. Commun., 2000, 275, 825-830.
104. Dekigai, H.; Nakamura, H.; Bai, J.; Tanito, M.; Masutani, H.; Hirota, K.; Matsui, H.; Murakami, M.; Yodoi J. Geranylgeranylacetone promotes induction and secretion of thioredoxin in gastric mucosal cells and peripheral blood lymphocytes. Free Radical Res., 2001, 35, 23-30. (Pubitemid 32725622)
105. Tanito, M.; Kwon, Y-W.; Kondo, N.; Bai, J.; Masutani, H.; Nakamura, H.; Fujii, J.; Ohira, A.; Yodoi, J. Cytoprotective effects of geranylgeranylacetone against retinal photooxidative damage. J. Neurosci., 2005, 25, 2396-2404. (Pubitemid 40322281)
106. Choi, H.S.; Shim, J.S.; Kim, J-A.; Kang, S.W.; Kwon, H.J. Discovery of gliotoxin as a new small molecule targeting thioredoxin redox system. Biochem. Biophys. Res. Commun., 2007, 359, 523-528.